Beranda › Glioma Pontin Intrinsik Difus › Washington
Uji klinis Glioma Pontin Intrinsik Difus di Washington
10 studi untuk Glioma Pontin Intrinsik Difus mencari peserta di lokasi di Washington.
Kota di Washington
Teks studi resmi (Bahasa Inggris)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676Targeted Pediatric High-Grade Glioma Therapy
- Seattle Children's Hospital, Seattle
Menerima pesertaStudi observasional
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07680439Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Seattle Children's Hospital, Seattle
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
Usia 2 hingga 39 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 2
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
- Seattle Children's Hospital, Seattle
Menerima pesertaFase 1
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT04185038A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Seattle Children's Hospital, Seattle
Menerima pesertaFase awal 1
Hingga usia 21 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04655404Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.